tiprankstipranks
Advertisement
Advertisement

PCAIGNO Stock Latest News

Aignostics Expands Cancer Data Platforms and Deepens AI Oncology Partnerships
Private CompaniesAignostics Expands Cancer Data Platforms and Deepens AI Oncology Partnerships
3h ago
AIGNO
Aignostics Expands OpenTME Cancer Image Dataset With New Indications
PremiumPrivate Companies
Aignostics Expands OpenTME Cancer Image Dataset With New Indications
2d ago
AIGNO
Aignostics Deepens AI Oncology Footprint With PanCAN Partnership and Bayer-Backed Platform
PremiumPrivate Companies
Aignostics Deepens AI Oncology Footprint With PanCAN Partnership and Bayer-Backed Platform
7d ago
AIGNO
Aignostics Partners With PanCAN to Power AI-Driven Pancreatic Cancer Data Platform
PremiumPrivate Companies
Aignostics Partners With PanCAN to Power AI-Driven Pancreatic Cancer Data Platform
11d ago
AIGNO
Aignostics Taps PanCAN’s SPARK Dataset to Expand AI-Driven Spatial Profiling in Pancreatic Cancer
PremiumPrivate Companies
Aignostics Taps PanCAN’s SPARK Dataset to Expand AI-Driven Spatial Profiling in Pancreatic Cancer
11d ago
AIGNO
Aignostics Highlights Bayer-Backed Multimodal AI Platform for Oncology Target Discovery
PremiumPrivate CompaniesAignostics Highlights Bayer-Backed Multimodal AI Platform for Oncology Target Discovery
12d ago
AIGNO
Aignostics Showcases Bayer-Backed AI Platform for Oncology Target Discovery
Premium
Private Companies
Aignostics Showcases Bayer-Backed AI Platform for Oncology Target Discovery
12d ago
AIGNO
Aignostics Gains Momentum With Bayer AI Validation, Data Expansion, and EIC Scale-Up Recognition
Premium
Private Companies
Aignostics Gains Momentum With Bayer AI Validation, Data Expansion, and EIC Scale-Up Recognition
28d ago
AIGNO
Aignostics Highlights AI-Based Target Identification Platform Validated With Bayer
PremiumPrivate Companies
Aignostics Highlights AI-Based Target Identification Platform Validated With Bayer
1M ago
AIGNO
Aignostics – Weekly Recap
PremiumPrivate Companies
Aignostics – Weekly Recap
1M ago
AIGNO
Aignostics Expands OpenTME Cancer Dataset With Free Large-Scale Release
PremiumPrivate Companies
Aignostics Expands OpenTME Cancer Dataset With Free Large-Scale Release
1M ago
AIGNO
Aignostics Expands OpenTME Cancer Image Dataset With Large-Scale Free Release
PremiumPrivate Companies
Aignostics Expands OpenTME Cancer Image Dataset With Large-Scale Free Release
1M ago
AIGNO
EIC STEP Scale Up Selection Enhances Aignostics’ Growth and Funding Prospects
PremiumPrivate CompaniesEIC STEP Scale Up Selection Enhances Aignostics’ Growth and Funding Prospects
1M ago
AIGNO
Aignostics Selected for EIC STEP Scale Up Program, Positioned for EU-Backed Growth Funding
Premium
Private Companies
Aignostics Selected for EIC STEP Scale Up Program, Positioned for EU-Backed Growth Funding
1M ago
AIGNO
Aignostics Expands Open-Access AI Pathology Tools and Academic Programs While Broadening Cancer Coverage
Premium
Private Companies
Aignostics Expands Open-Access AI Pathology Tools and Academic Programs While Broadening Cancer Coverage
2M ago
AIGNO
Aignostics Highlights Talent Pipeline and Diversity Efforts With Girls’ Day Event
PremiumPrivate Companies
Aignostics Highlights Talent Pipeline and Diversity Efforts With Girls’ Day Event
2M ago
AIGNO
Aignostics Expands Academic Access to Spatial Tumor Microenvironment Tool
PremiumPrivate Companies
Aignostics Expands Academic Access to Spatial Tumor Microenvironment Tool
2M ago
AIGNO
Aignostics Expands Academic Access to Tumor Microenvironment Analytics
PremiumPrivate Companies
Aignostics Expands Academic Access to Tumor Microenvironment Analytics
2M ago
AIGNO
Aignostics Leans on Open-Access Data, Academic Programs, and New Cancer Indications to Build AI Pathology Reach
PremiumPrivate Companies
Aignostics Leans on Open-Access Data, Academic Programs, and New Cancer Indications to Build AI Pathology Reach
2M ago
AIGNO
Aignostics Expands Access to AI Pathology Data With OpenTME Dataset
PremiumPrivate CompaniesAignostics Expands Access to AI Pathology Data With OpenTME Dataset
2M ago
AIGNO
Aignostics Expands Access to Cancer Image Analysis With OpenTME Dataset
Premium
Private Companies
Aignostics Expands Access to Cancer Image Analysis With OpenTME Dataset
2M ago
AIGNO
Aignostics Highlights Atlas H&E-TME Access for Researchers and Biopharma at AACR 2026
Premium
Private Companies
Aignostics Highlights Atlas H&E-TME Access for Researchers and Biopharma at AACR 2026
2M ago
AIGNO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >